SLDB
Solid Biosciences·NASDAQ
--
--(--)
--
--(--)
5.16 / 10
Netural
Capital flow assessment yields 7.57/10, denoting robust fund flow characteristics. Strengths in no significant trends trends confront pressures from overall, block, Small, Medium, Large, and Extra-large patterns, resulting in positive liquidity outlook. Analyst coverage indicates overwhelmingly bullish analyst consensus with strong conviction. Rating distribution: Strong Buy(100.0%) among 1 analysts, supported by 2.75 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-14
InstitutionNeedham
Times predicted2
Historical Win Rate50.0%
What is the market sentiment for SLDB?
- SLDB holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.16/10 (Netural).
